ArticleCureus2025
The Effectiveness of Structured Neurologic Music Therapy on Phonation and Breathing Function Following COVID-19.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective To analyze the effectiveness of neurologic music therapy (NMT), consisting of diaphragmatic breathing (DB), vocal intonation therapy (VIT), and therapeutic singing (TS), on sustained phonation and oxygen use during recovery from the recent coronavirus disease 2019 (COVID)-19 or post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) (PASC). Methods The study was designed as a retrospective cohort study. Sixty-nine adults admitted to acute inpatient rehabilitation with recent COVID-19 or PASC received standard physical, occupational, speech, and respiratory therapies. All were given a graded exhalation device with vibratory stimulation to help strengthen the muscles of expiration and clear secretions. Bronchodilators were administered as needed. Supplemental oxygen was prescribed to maintain saturations >92%. Thirty-three individuals also chose to receive NMT 1-3 times weekly for the duration of their inpatient rehabilitation hospitalization. The main outcome measures were changes in oxygen demand during rehabilitation and breath control, defined as sustained phonation (expiration) from a single breath. Secondary outcomes were discharge disposition and NMT participant experience. Results Compared with the non-NMT group, NMT participants required significantly more oxygen during activity at both admission (p=.010) and discharge (p=.007). Within the NMT group, significant improvement in oxygen demand was observed from admission to discharge, both at rest (.7833L reduction, p=.003) and during activity (.8500L reduction, p=.003). The degree of improvement in the need for oxygen also showed differences between the two groups. Compared with non-NMT participants, those receiving NMT demonstrated a significantly greater reduction in activity-based oxygen use during rehabilitation (p=.014, Cohen's d 2.06). Despite a longer duration in acute care than the non-NMT group, the NMT participants had an equivalent number of days in inpatient rehabilitation and a higher rate of home discharge (p=.018). Positive correlations were found in changes in phonation abilities, measured by the number of NMT sessions completed (p=.021) and by minutes of NMT received (p=.009). The majority of participants rated their experience with this program as positive. Discussion Proper DB with VIT and TS can have a meaningful effect on sustained phonation, breathing tolerance, and vocalization, resulting in participants reporting fewer pauses for air while speaking. NMT was considered a positive experience that also potentially contributed to the reduction in oxygen dependence after COVID-19.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.